787TiPA phase III study of adjuvant docetaxel, capecitabine and oxaliplatin triplet vs capecitabine and oxaliplatin doublet in patients with curatively resected stage IIIB or IV(M0) (AJCC 6th ed) gastric adenocarcinoma (TRIUMPH, KCSG ST14-05)
Ryu, M-H, Zang, D Y, Lee, K-W, Shim, B Y, Lee, M H, Rha, S Y, Kang, Y-KVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy282.170
Date:
October, 2018
File:
PDF, 75 KB
2018